SRC and gastric adenocarcinoma: Subtype-specific investigations revealed that SRC and PINK1 expression varied significantly among subtypes 1–4 in KIRC, stomach adenocarcinoma (STAD) and BRCA molecular subtypes (Basal, Her2, LumA, LumB, normal-like).